Optimized furosemide taste masked orally disintegrating tablets

被引:22
|
作者
Ibrahim, Mohamed Abbas [1 ,2 ]
Abou El Ela, Amal El Sayeh F. [1 ,3 ]
机构
[1] King Saud Univ, Dept Pharmaceut, Coll Pharm, Riyadh, Saudi Arabia
[2] Al Azhar Univ, Dept Pharmaceut & Ind Pharm, Coll Pharm, Assiut, Egypt
[3] Assiut Univ, Dept Pharmaceut, Coll Pharm, Assiut 71526, Egypt
关键词
Furosemide; Orally disintegrating tablets (ODTs); Eudragit E100; Optimization; Taste masking; Superdisinitgrant; CYCLODEXTRIN INCLUSION COMPLEX; SOLID DISPERSION; BIOAVAILABILITY; FORMULATION; MASKING; DRUGS;
D O I
10.1016/j.jsps.2017.04.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Optimized orally disintegrating tablets (ODTs) containing furosemide (FUR) were prepared by direct compression method. Two factors, three levels (3(2)) full factorial design was used to optimize the effect of taste masking agent (Eudragit E100; X1) and superdisintegarant; croscarmellose sodium (CCS; X2) on tablet properties. A composite was prepared by mixing ethanolic solution of FUR and Eudragit E100 with mannitol prior to mixing with other tablet ingredients. The prepared ODTs were characterized for their FUR content, hardness, friability and wetting time. The optimized ODT formulation (F1) was evaluated in term of palatability parameters and the in vivo disintegration. The manufactured ODTs were complying with the pharmacopeia guidelines regarding hardness, friability, weight variation and content. Eudragit E100 had a very slightly enhancing effect on tablets disintegration. However, the effects of both Eudragit E100 (X1) and CCS (X2) on ODTs disintegration time (Y1) were insignificant (p > 0.05). Moreover, X1 exhibited antagonistic effect on the dissolution after 5 and 30 min (D5 and D30, respectively), but only its effect on D30 is significant (p = 0.0004). Furthermore, the optimized ODTs formula showed good to acceptable taste in term of palatability, and in vivo disintegration time of this formula was about 10 s. (C) 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:1055 / 1062
页数:8
相关论文
共 50 条
  • [21] Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets
    Malladi, Madhusudhan
    Jukanti, Raju
    Nair, Rashmi
    Wagh, Sanjay
    Padakanti, Hari Shanker
    Mateti, Ashok
    [J]. ACTA PHARMACEUTICA, 2010, 60 (03) : 267 - 280
  • [22] Formulation, Preparation, and Evaluation of Novel Orally Disintegrating Tablets Containing Taste-Masked Naproxen Sodium Granules and Naratriptan Hydrochloride
    Stange, Ulrike
    Fuehrling, Christian
    Gieseler, Henning
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (04) : 1233 - 1245
  • [23] A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate
    Liu, Yali
    Li, Peng
    Qian, Rong
    Sun, Tianyu
    Fang, Fangzhi
    Wang, Zonghua
    Ke, Xue
    Xu, Bohui
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (08) : 1317 - 1327
  • [24] Development and Evaluation of Cetirizine HCl Taste-Masked Oral Disintegrating Tablets
    Douroumis, Dionysios Dennis
    Gryczke, Andreas
    Schminke, Silke
    [J]. AAPS PHARMSCITECH, 2011, 12 (01): : 141 - 151
  • [25] Formulation and In Vitro Evaluation of Taste-Masked Fast Disintegrating Tablets of Prednisolone
    Alipour, Shohreh
    Parhizkar, Elahehnaz
    Farrahi, Haleh
    Ahmadi, Fatemeh
    [J]. LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (05): : 980 - 986
  • [26] Development and Evaluation of Cetirizine HCl Taste-Masked Oral Disintegrating Tablets
    Dionysios Dennis Douroumis
    Andreas Gryczke
    Silke Schminke
    [J]. AAPS PharmSciTech, 2011, 12 : 141 - 151
  • [27] Losartan Potassium Taste-masked Oral Disintegrating Tablets for Hypertensive Patients
    Shazly, Gamal A.
    Ibrahim, Mohamed A.
    [J]. LATIN AMERICAN JOURNAL OF PHARMACY, 2016, 35 (01): : 110 - 117
  • [28] Orally Disintegrating Tablets: A Review
    Hirani, Jaysukh J.
    Rathod, Dhaval A.
    Vadalia, Kantilal R.
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2009, 8 (02) : 161 - 172
  • [29] Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use
    Comoglu, Tansel
    Ozyilmaz, Emine Dilek
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2019, 24 (07) : 902 - 914
  • [30] Citric Acid Suppresses the Bitter Taste of Olopatadine Hydrochloride Orally Disintegrating Tablets
    Sotoyama, Mai
    Uchida, Shinya
    Tanaka, Shimako
    Hakamata, Akio
    Odagiri, Keiichi
    Inui, Naoki
    Watanabe, Hiroshi
    Namiki, Noriyuki
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (04) : 451 - 457